Citation:Spelman L, Rosen R, Knudsen KM, Zibert JR, Freeman M 2018

From Cancer Guidelines Wiki

Citation


Spelman L, Rosen R, Knudsen KM, Zibert JR, Freeman M. Ingenol mebutate 0.05% gel under occlusion is efficacious in treating superficial basal cell carcinoma. B J Dermatol. 2014;171(Suppl. 4):58–9.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What role does Ingenol mebutate gel have in the treatment and management of basal cell and/or squamous cell carcinomas?Dr Albert Chetcuti BTech(Biotech) Hons, PhDcompleted
What role does Ingenol mebutate gel have in the treatment and management of basal cell and/or squamous cell carcinomas?Annie Bygravecompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What role does Ingenol mebutate gel have in the treatment and management of basal cell and/or squamous cell carcinomas?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What role does Ingenol mebutate gel have in the treatment and management of basal cell and/or squamous cell carcinomas?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What role does Ingenol mebutate gel have in the treatment and management of basal cell and/or squamous cell carcinomas?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What role does Ingenol mebutate gel have in the treatment and management of basal cell and/or squamous cell carcinomas?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. 10.1 The role of topical treatments in the treatment of keratinocyte cancer